Cellularis Biomodels

📣 WE ARE HIRING! 📣 Are you ready to make a mark in the future of gene therapy? At Cellularis Biomodels, we are seeking a talented and driven Master or PhD student to join our groundbreaking European Project EdigenT, focused on new prime editing and non-viral delivery strategies for gene therapy. 📍 Location: Full Time 📅 Application Deadline: March 21th 💼 Apply Here, send your CV and letter via mail to: cellularis.biomodels@outlook.com 🔗 Learn more about us : https://lnkd.in/dRAxQUBy and about the EdigenT project: https://lnkd.in/dxJvwcht This is your chance to contribute to the next wave of gene-editing innovation and help shape the future of therapeutic development. Are you ready to make a difference? #GeneTherapy #Innovation #Liposomes #GeneDelivery #Nanoparticles #EdigenT #CellularisBiomodels

🔬 Celebrating Women in Science 🔬   Today, on the International Day of Women and Girls in Science, we celebrate the brilliant women who drive innovation, discovery, and progress—especially the incredible women on our team! 💡💪   At Cellularis Biomodels, we believe that science should not be divided, neither by barriers nor by gender. When everyone supports scientific development, the world moves forward together. 🌍✨   There is no gender when we wear our lab coats. Just passion, curiosity, and the drive to make a difference. 🚀   💬 Join us in celebrating women in science! Tag a woman who inspires you and share their impact. #WomenInScience #InternationalDayOfWomenInScience #FutureOfScience 

🧬 Crack the Cancer Code   Today, on World Cancer Day, we come together to tackle one of humanity’s greatest challenges. At Cellularis Biomodels, we’re advancing the fight against cancer by developing 3D in vitro tumor models that replicate the complexities of the tumor microenvironment (TME). These breakthroughs help us accelerate the discovery of effective, personalized therapies.   🧪 But Can YOU Crack the Cancer Code? Put your knowledge to the test with our quick quiz!    🔗 Click to Play https://lnkd.in/dpAceg4z 🎯 Why Play? Because science is teamwork, and every effort counts. Together, we can decode cancer and take another step toward a brighter, healthier future. Let’s unite for progress. Let’s innovate for cures. Let’s win this fight—together.   #WorldCancerDay #CrackTheCancerCode #3DModelsInResearch #InnovatingForCures

✨ Starting the Year on a High Note! ✨ Last night the Cellularis Biomodels team came together for a memorable dinner to celebrate the start of an exciting new chapter. 🚀 It was more than just an evening of delicious food and great company - it was a chance to reflect on our accomplishments, strengthen our bonds, and set the stage for what's to come. The energy and dedication of our team is truly inspiring, and we can't wait to see what we can accomplish together in 2025. 🤝 Here's to a year of collaboration, innovation and success. Here's to the incredible Cellularis family! 🥂 #Cellularis #NewYear2025 #Teamwork

🌟 Cellularis Biomodels Hosted the INSPIRE Project Meeting in Aveiro Last week, Cellularis Biomodels had the privilege of hosting a key meeting of INSPIRE European project in the city of Aveiro. The INSPIRE project focuses on developing a new therapeutic strategy to fight lung cancer. Cellularis is playing a pivotal role in the development of bioengineered lung tumor models, providing invaluable insights into the tumor microenvironment and helping to accelerate the benchmarking of such innovative lung cancer therapies. Read more about the project here 👉 https://lnkd.in/dvfUKqgj The meeting brought together key partners from across the project to discuss the progress of our collaborative efforts, share ideas and strengthen the partnership. We are excited to continue working with our esteemed partners, DKFZ German Cancer Research Center, OmniSpirant Limited, EVerZom, Aerogen, RemedyBio, Trinity College Dublin and PharmaLex to advance this landmark approach and look forward to sharing more updates soon! 🙌 We thank all of our partners for their commitment to innovation, PCI · Creative Science Park Aveiro Region for their support and the entire Cellularis team for their dedication and hard work, Luís F., Margarida Pereira, Nelson O. Monteiro, Cátia Teixeira, João F. Mano and Vítor Gaspar. #CellularisBiomodels #INSPIREProject #InnovationInScience #LungCancerResearch #CollaborationForImpact

📢 New Technology : Cellularis Biomodels is moving up the scale to provide millimeter sized human in vitro models 3D models have been limited to the micrometer scale, but our team has taken these models to a new level - MILIMITER size! 🌐 Our new models not only extend to the millimeter scale, but also integrate complex tumor-stroma architectures, capturing the cellular heterogeneity and matrix density found in native tumor tissue. This advance brings us closer to biofabricating organotypic models that capture the architecture and size of native human tumors, opening new avenues for evaluating therapeutic efficacy in a setting that more closely mirrors the human tumor environment than ever before. 🔗 Curious to dive deeper? Read the full paper here: https://lnkd.in/d8nb4iai #CancerResearch #3DBioprinting #InVitroModels #PancreaticCancer #DrugScreening #Innovation

🤝 Cellularis Biomodels at EdiGenT Meeting: Strengthening Partnerships Last week, our member´s team, Nelson O. Monteiro, João F. Mano and Vítor Gaspar had the privilege of meeting with the EdiGenT project partners at the ZeClinics headquarters in Sant Feliu de Llobregat, Barcelona. As part of the European consortium, Cellularis Biomodels is working with leading organizations dedicated to advancing innovative nanodelivery systems for gene editing. 🔬 This meeting assessed EdiGenT's progress and fostered closer collaboration between our partners. Discussions covered the latest advances in our work, also focuse on the development of 3D in vitro platforms to screen gene editing therapeutics. Thank you to ZeClinics for hosting and to all of our partners, Erasmus MC Academie, INSERM Institut national de la santé et de la recherche médicale, and Institut Imagine for their valuable contributions and dedication to this transformative project. 🌐 Stay tuned for further updates! #CellularisBiomodels #Nanodelivery #EdiGenT #Innovation #Geneediting #3Dinvitromodels

🚀 Cellularis at ESGCT 2024: Advancing Gene Editing Delivery Technologies We are proud to announce that one of our talented team members, Nelson O. Monteiro, recently attended the 2024 Congress of the European Society for Gene and Cell Therapy (ESGCT), held in the beautiful city of Rome! 🌍🇮🇹 During this event, Nelson presented his research on the supramolecular functionalization of nanoparticles for the delivery of gene editing machinery  📍Poster number: P0925 This innovative work is part of the European EdiGenT project, in which Cellularis plays a key role in the development of advanced nanodelivery systems. This research represents a significant step forward in improving the delivery and precision of gene editing approaches - paving the way for potential therapeutic applications in the future. Congratulations to our team for this important achievement, and a big thank you to the ESGCT 2024 for hosting such an inspiring event! 🙌 #GeneEditing #Nanotechnology #Nanoparticles #CellTherapy #ESGCT #Innovation #Cellularis

🚀 Welcome aboard! 🚀   We are excited to announce the arrival of our new trainees, Bárbara Ferreira, Edite Oliveira and Mafalda Borralho, to the Cellularis Biomodels family!    As a startup dedicated to pioneering 3D disease models, we're excited to have fresh talent and innovative minds join us in our mission. 🔬   Let's welcome our new trainees! We're looking forward to supporting your growth and innovation as we embark on this journey together. Here's to new beginnings, inspiring collaborations and a bright future ahead!   #Welcome #NewTrainees #Cellularis #3DDiseaseModels #Innovation #Teamwork

🏆 Cellularis Biomodels wins 3rd place at the INOVA+ 2024 Awards 🏆 We are happy to announce that Cellularis Biomodels was awarded 3rd place in the Scientific Innovation category at the prestigious INOVA+ 2024 Awards! This recognition further stimulates our dedication to pushing the boundaries of scientific innovation in the field of advanced human cell-based in vitro models for screening therapeutics and biomarkers discovery. We acknowledge our team that was greatly involved, especially Mariana Carvalho, Inês Freitas, professor Vítor Gaspar and professor João F. Mano. We would also like to thank the organizers and partners of the event, including the National Innovation Agency (ANI), the Confederation of Portuguese Industries (AIP), the Coordinating Council of Higher Polytechnic Institutes (CCISP), the Council of Rectors of Portuguese Universities (CRUP), and the Directorate General of the Arts (DGArtes) for this honor. On to more innovation and breakthroughs! 🚀 #Inova #ScientificInnovation #InnovationExcellence #Teamwork #CellularisBiomodels #InnovationLeadership